EUVIMEDEUVIMED entdecken
Open Access

Myo-inositol attenuates diabetes-induced testicular injury through Nrf2/Bcl-2 signaling in rats

Mina Kiani, Malek Soleimani Mehranjani, Mohammad Ali Shariatzadeh

Journal of Diabetes & Metabolic Disorders · 11.08.2026 · 25 (2)

DOI: 10.1007/s40200-026-02049-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes & Metabolic Disorders, online erschienen am 11.08.2026. Verfasst von Mina Kiani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Razi University, Kermanshah, 6714414971 Iran. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Insulin resistance from pancreatic beta cell malfunction causes type 2 diabetes mellitus (T2DM), hyperlipidemia, and disrupting the endocrine system. Due to its antioxidant and insulin-mimetic properties, myo-inositol (MI) can enhance insulin sensitivity, thereby reducing oxidative stress and inflammation. This study examined MI 's antiglycemic, antioxidant effects, and potential to reduce insulin resistance, focusing on its impact on serum markers, testicular health and, apoptosis regulation in rats with T2DM.

Methods

The study investigated testicular histology, serum and tissue biochemistry, gene and protein expression, and inflammatory factors in rats with T2DM.

Results

MI treatment significantly increased the overall testis volume, including its components, and the average number of spermatogenic and somatic cells, which had decreased in the T2DM group. In the T2DM + MI group, levels of testicular testosterone, superoxide dismutase (SOD), total antioxidant capacity (TAC), nuclear factor erythroid 2-related factor 2 (Nrf2), and Bcl2 gene and protein expression significantly increased, while serum total cholesterol, low-density lipoprotein cholesterol (LDL-C), testicular malondialdehyde (MDA), tumor necrosis factor alpha (TNF-α), Interleukin - 6( IL-6), and Bax gene and protein expression decreased compared to the T2DM group.

Conclusion

MI treatment may counteract diabetes-induced damage to testicular histology and spermatogenesis by reducing oxidative stress, apoptosis, and inflammation through activation of the Nrf2 / Bcl2 pathways.

Schlagwörter

Stichwörter der Autor:innen

Bax/Bcl-2 signalingDiabetesMyoinositolNrf2Testis

Autor:innen und Institutionen

  • Department of Biology, Faculty of Science, Razi University, Kermanshah, 6714414971 Iran.
  • Department of Biology, Faculty of Science, Arak University, Arak, 384817758 Iran.

Zitieren

APA

Kiani, M., Mehranjani, M. S., & Shariatzadeh, M. A. (2026). Myo-inositol attenuates diabetes-induced testicular injury through Nrf2/Bcl-2 signaling in rats. Journal of Diabetes & Metabolic Disorders, 25(2). https://doi.org/10.1007/s40200-026-02049-5

Vancouver

Kiani M, Mehranjani MS, Shariatzadeh MA. Myo-inositol attenuates diabetes-induced testicular injury through Nrf2/Bcl-2 signaling in rats. Journal of Diabetes & Metabolic Disorders. 2026;25(2). doi:10.1007/s40200-026-02049-5

BibTeX
@article{Kiani2026,
  author = {Kiani, Mina and Mehranjani, Malek Soleimani and Shariatzadeh, Mohammad Ali},
  title = {Myo-inositol attenuates diabetes-induced testicular injury through Nrf2/Bcl-2 signaling in rats},
  journal = {Journal of Diabetes & Metabolic Disorders},
  year = {2026},
  volume = {25},
  number = {2},
  doi = {10.1007/s40200-026-02049-5}
}
Kostenlos starten →